Bingyu Li

发表

CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy

Lijun Xu, K. Xie, Jianmin Fang, 2018, Oncoimmunology.

Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy

Dong Li, Lijun Xu, K. Xie, 2016, PloS one.

Adaptive resistance in tumors to anti-PD-1 therapy through re-immunosuppression by upregulation of GPNMB expression.

Jingming Zhang, T-G Huang, K. Xie, 2021, International immunopharmacology.

Intelligent Biomimetic Nanoplatform for Systemic Treatment of Metastatic Triple-Negative Breast Cancer via Enhanced EGFR-Targeted Therapy and Immunotherapy.

Yun Zhang, Yanfeng Gao, Yan Wang, 2022, ACS applied materials & interfaces.

Distributed Random Beacon for Blockchain Based on Share Recovery Threshold Signature

Zhenyang Ding, Yang Yang, Shengjie Hou, 2022, Sensors.

Reversing PD-1 Resistance in B16F10 Cells and Recovering Tumour Immunity Using a COX2 Inhibitor

T-G Huang, K. Xie, Yan Feng, 2022, Cancers.

Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1

Jufeng Li, J. Li, Jie-Hui Li, 2020, Oncoimmunology.

CD47/SIRPα blocking enhances CD19/CD3-bispecific T cell engager antibody-mediated lysis of B cell malignancies.

Jie-Hui Li, Lijun Xu, Bingyu Li, 2019, Biochemical and biophysical research communications.

A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity

Yan Feng, Jingming Zhang, K. Xie, 2022, Life.

Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade

K. Xie, Yan Feng, Jian-min Fang, 2022, Journal for ImmunoTherapy of Cancer.

An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy.

Yanfeng Gao, Y. Qi, Jiangfeng Du, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo

J. Larrick, Lijun Xu, A. Mendelsohn, 2017, Oncotarget.

A Three-In-One Assembled Nanoparticle Containing Peptide-Radio-Sensitizer Conjugate and TLR7/8 Agonist Can Initiate the Cancer-Immunity Cycle to Trigger Antitumor Immune Response.

Yun Zhang, Yanfeng Gao, Yan Wang, 2022, Small.

The role of Fas-FasL-FADD signaling pathway in arsenic-mediated neuronal apoptosis in vivo and in vitro.

Dianjun Sun, Zhe Jiao, Yuting Jiang, 2021, Toxicology letters.

Integrating angiogenesis signature and tumor mutation burden for improved patient stratification in immune checkpoint blockade therapy for muscle-invasive bladder cancer.

Y. Zhu, Le Xu, Jiejie Xu, 2023, Urologic oncology.